<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38093182</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>13</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Prevalence of covid-19 and long covid in collegiate student athletes from spring 2020 to fall 2021: a retrospective survey.</ArticleTitle><Pagination><StartPage>876</StartPage><MedlinePgn>876</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">876</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08801-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Symptomatic COVID-19 and Long COVID, also referred to as post-acute sequelae of SARS-CoV-2 (PASC) or post-COVID conditions, have been widely reported in young, healthy people, but their prevalence has not yet been determined in student athletes. We sought to estimate the prevalence of reported COVID-19, symptomatic COVID-19, and Long COVID in college athletes in the United States attending 18 schools from spring 2020 to fall 2021.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We developed an online survey to measure the prevalence of student athletes who tested positive for COVID-19, developed Long COVID, and did not return to their sport during the relevant time period. We surveyed a convenience sample of 18 collegiate school administrators, representing about 7,000 student athletes. Of those schools surveyed, 16 responded regarding the spring 2020 semester, and 18 responded regarding the full academic year of fall 2020 to spring 2021 (both semesters).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">According to the survey responses, there were 9.8% of student athletes who tested positive for COVID-19 in spring 2020 and 25.4% who tested positive in the academic year of fall 2020 to spring 2021. About 4% of student athletes who tested positive from spring 2020 to spring 2021 developed Long COVID, defined as new, recurring, or ongoing physical or mental health consequences occurring 4 or more weeks after SARS-CoV-2 infection.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study highlights that Long COVID occurs among young, healthy athletes and is a real consequence of COVID-19. Understanding the prevalence of Long COVID in this population requires longer follow-up and further study.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Massey</LastName><ForeName>Daisy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale New Haven Hospital, 195 Church Street, Fifth Floor, New Haven, CT, 06510, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saydah</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Coronaviruses and Other Respiratory Viruses Division, Epidemiology Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamson</LastName><ForeName>Blythe</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>COVID-19 Sports and Society Working Group, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Economics, LLC, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Comparative Health Outcomes, Policy and Economics Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lincoln</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>COVID-19 Sports and Society Working Group, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Special Olympics, Washington D.C., USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aukerman</LastName><ForeName>Douglas F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>COVID-19 Sports and Society Working Group, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Samaritan Athletic Medicine at Oregon State University, Samaritan Health Services, Corvallis, OR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berke</LastName><ForeName>Ethan M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>COVID-19 Sports and Society Working Group, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UnitedHealth Group, Minnetonka, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sikka</LastName><ForeName>Robby</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>COVID-19 Sports and Society Working Group, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale New Haven Hospital, 195 Church Street, Fifth Floor, New Haven, CT, 06510, USA. harlan.krumholz@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID-19 Sports and Society Working Group, Minneapolis, MN, USA. harlan.krumholz@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. harlan.krumholz@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA. harlan.krumholz@yale.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056352" MajorTopicYN="N">Athletes</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013334" MajorTopicYN="N">Students</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Athletes</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">College</Keyword><Keyword MajorTopicYN="N">Healthy</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Sports</Keyword><Keyword MajorTopicYN="N">Young</Keyword></KeywordList><CoiStatement>In the past three years, Harlan Krumholz received expenses and/or personal fees from Element Science, Eyedentify, and F-Prime. He is a co-founder of HugoHealth,&#xa0;Refactor Health, and Ensight-AI. He&#xa0;is the co-editor of Journal Watch: Cardiology of the Massachusetts Medical Society and is a section editor of UpToDate. He is associated with contracts, through Yale New Haven Hospital, from the Centers for Medicare &amp; Medicaid Services and, through Yale University, from Janssen,&#xa0;Johnson &amp; Johnson&#xa0;Consumer, and Pfizer. The other authors report no potential conflicting interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>13</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38093182</ArticleId><ArticleId IdType="pmc">PMC10717379</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08801-z</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08801-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CDC. Your Health: Post-COVID Conditions. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html. Published 2021. Updated September 16, 2021. Accessed 3 Apr 2022.</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nature Medicine. 2021;27(4):626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, Asgari Mehrabadi M, Abrahim HL, Dutt N, Lambert N, Nurmi EL, Chakraborty R, Rahmani AM, Downs CA. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler Looking for Clarity in the Haze of the Pandemic. Clin Nurs Res. 2022;31(8):1390&#x2013;8. 10.1177/10547738221125632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. 2022;37(5):539&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanga V, Chevinsky JR, Dimitrov LV, et al. Long-term symptoms among adults tested for SARS-CoV-2 - United States, January 2020-April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(36):1235&#x2013;1241. doi: 10.15585/mmwr.mm7036a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7036a1</ArticleId><ArticleId IdType="pmc">PMC8437054</ArticleId><ArticleId IdType="pubmed">34499626</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. Office for National Statistics UK; 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/latest. Accessed 11 Mar 2022.</Citation></Reference><Reference><Citation>Schultz EA, Kussman A, Jerome A, Abrams GD, Hwang CE. Comparison of SARS-CoV-2 test positivity in NCAA division I student athletes vs nonathletes at 12 institutions. JAMA Netw Open. 2022;5(2):e2147805&#x2013;e2147805. doi: 10.1001/jamanetworkopen.2021.47805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.47805</ArticleId><ArticleId IdType="pmc">PMC8829663</ArticleId><ArticleId IdType="pubmed">35138397</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao P, Peritz DC, Systrom D, Lewine K, Cornwell WK, 3rd, Hsu JJ. Orthostatic and exercise intolerance in recreational and competitive athletes with long COVID. JACC Case Rep. 2022;4(17):1119&#x2013;1123. doi: 10.1016/j.jaccas.2022.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2022.07.007</ArticleId><ArticleId IdType="pmc">PMC9450930</ArticleId><ArticleId IdType="pubmed">36090156</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwendinger F, Knaier R, Radtke T, Schmidt-Trucks&#xe4;ss A. Low cardiorespiratory fitness post-COVID-19: a narrative review. Sports Med. 2023;53(1):51&#x2013;74. doi: 10.1007/s40279-022-01751-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-022-01751-7</ArticleId><ArticleId IdType="pmc">PMC9483283</ArticleId><ArticleId IdType="pubmed">36115933</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. The Possibility of COVID-19 after Vaccination: Breakthrough Infections. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness/why-measure-effectiveness/breakthrough-cases.html. Published 2021. Updated December 17, 2021. Accessed 3 Apr 2022.</Citation></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10):e2128568&#x2013;e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Casasco M, Iellamo F, Scorcu M, et al. Return to play after SARS-CoV-2 infection in competitive athletes of distinct sport disciplines in Italy: a FMSI (Italian Federation of Sports Medicine) study. J Cardiovasc Dev Dis. 2022;9(2):59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8874550</ArticleId><ArticleId IdType="pubmed">35200712</ArticleId></ArticleIdList></Reference><Reference><Citation>Guevarra CC, Murray N, Cipriani D, et al. Cardiovascular involvement among collegiate athletes following COVID-19 infection. J Clin Transl Res. 2022;8(1):1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8791243</ArticleId><ArticleId IdType="pubmed">35097235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakatos BK, Tokodi M, F&#xe1;bi&#xe1;n A, et al. Frequent constriction-like echocardiographic findings in elite athletes following mild COVID-19: a propensity score-matched analysis. Front Cardiovasc Med. 2021;8:760651. doi: 10.3389/fcvm.2021.760651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.760651</ArticleId><ArticleId IdType="pmc">PMC8767617</ArticleId><ArticleId IdType="pubmed">35071343</ArticleId></ArticleIdList></Reference><Reference><Citation>Radin JM, Quer G, Ramos E, et al. Assessment of prolonged physiological and behavioral changes associated with COVID-19 infection. JAMA Netw Open. 2021;4(7):e2115959. doi: 10.1001/jamanetworkopen.2021.15959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.15959</ArticleId><ArticleId IdType="pmc">PMC8264646</ArticleId><ArticleId IdType="pubmed">34232306</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>